The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria
- 358 Downloads
To determine the pharmacokinetic properties of atovaquone, proguanil, and the triazine metabolite cycloguanil in women with recrudescent multi-drug resistant falciparum malaria during the second and third trimesters of pregnancy treated by artesunate-atovaquone-proguanil.
Serial plasma concentrations of atovaquone, proguanil and cycloguanil were measured in 24 women at baseline and after the final dose of the 3-day treatment with atovaquone (20 mg/kg/day) plus proguanil (8 mg/kg/day) plus artesunate (4 mg/kg/day) daily.
The triple combination was well tolerated and highly effective. The outcomes of pregnancy were all normal. Population mean (± SEM) oral clearance (Cl/F) estimates were 313±33 ml/h/kg and 1109±43 ml/h/kg, total apparent volume of distribution (Vd/F) 13.0±1.3 l/kg and 22.9±1.4 l/kg, and terminal elimination half-life; 29.1 h and 14.3 h, for atovaquone and proguanil, respectively. Using conventional and population pharmacokinetic analyses, Cl/F and Vd/F estimates for both drugs were approximately twice, and plasma concentrations less than half those reported previously in healthy subjects and patients with acute malaria.
Artesunate-atovaquone-proguanil is a promising treatment for multi-drug resistant falciparum malaria during pregnancy, but the dose of atovaquone-proguanil may need to be increased.
KeywordsP. falciparum Pregnancy Malaria
We thank the staff of the Shoklo Malaria Research Unit antenatal clinics for their help. This investigation was part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain.
- 1.Brockman A, Price RN, van Vugt M, Heppner DG, Walsh DS, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F (2000) Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive artesunate-mefloquine use. Trans R Soc Trop Med Hyg 94:537–544PubMedGoogle Scholar
- 2.McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F (2000) Randomized comparison of mefloquine-artesunate combination versus quinine in treatment of multi-drug resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 94:689–693PubMedGoogle Scholar
- 3.McGready R, Cho T, Khan Keo N, Thwai KL, S L, White NJ, Nosten F (2001) Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant P. falciparum. Clin Infec Dis 33:2009–2016Google Scholar
- 5.Product information, Malarone (atovaquone and proguanil hydrochloride). Physician's Desk Reference 2001; Medical Economics Company, Inc. Montvale (NJ), USAGoogle Scholar
- 8.McGready R, Khan Keo N, Villegas L, White NJ, Looareesuwan S, Nosten F (2003) Artesunate–atovaquone–proguanil rescue treatment of multidrug resistant falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg (in press)Google Scholar
- 15.Taylor RB, Moody RR, Ochekpe NA (1987) Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by HPLC. J Chromatogr 416:394–399Google Scholar
- 18.Hussein Z, Eaves J, Hutchinson D, Canfield C (1997) Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharm Therapeut 61:518–530Google Scholar
- 20.Sabcharoen A, Attanath P, Phanuaksook P, Chanthavanich P, Poonpanich Y,Mookmanee D, Chongsuphajaisiddhi T, Sadler BM, Hussein Z, Canfield CJ, Hutchinson DB (1998) Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 92:201–206PubMedGoogle Scholar
- 26.McGready R, Stepniewska K, Seaton E, Cho T, Cho D, Ginsburg A, Edstein MD, Ashley E, Looareesuwan S, White NJ, Nosten F. (2003) Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharm (this issue)Google Scholar